Rupture-prone plaque areas are known to be dominated by inflammatory macrophages19 and together with our observation that the levels of activated p-Acly were increased in inflammatory macrophages, this prompted us to study whether targeting macrophage Acly could improve atherosclerosis outcome. The gene discussed is ACLY; the disease is atherosclerosis.